UBS Group AG

Holdings History for Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

Symbol: CLYM on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$285,292	71,323	-334,081	-82%	$4.00	Q4 2025
30 Sep 2025	0%	+0%	$814,862	405,404	+22,922	+6%	$2.01	Q3 2025
30 Jun 2025	0%	0%	$474,278	382,482	+257	+0.07%	$1.24	Q2 2025
31 Mar 2025	0%	-0%	$466,314	382,225	-33,130		$1.22	Q1 2025
31 Dec 2024	0%	+0%	$747,639	415,355	+399,108	+2457%	$1.80	Q4 2024
30 Sep 2024	0%	+0%	$82,697	16,247	+14,029	+633%	$5.09	Q3 2024
30 Jun 2024	0%	-0%	$15,770	2,218	-3,707	-63%	$7.11	Q2 2024
31 Mar 2024	0%	+0%	$16,235	5,925	+5,925	NEW	$2.74	Q1 2024
31 Dec 2023		0%	$0	0	-89	-100%	$5.44	Q4 2023
30 Sep 2023	0%	0%	$234	89	+89	NEW	$2.63	Q3 2023
30 Sep 2022		-0%	$0	0	-2,282	-100%	$5.44	Q3 2022
30 Jun 2022	0%	+0%	$7,000	2,282	+666	+41%	$3.07	Q2 2022
31 Mar 2022	0%	-0%	$14,000	1,616	-2,822	-64%	$8.66	Q1 2022
31 Dec 2021	0%	-0%	$47,000	4,438	-9,435	-68%	$10.59	Q4 2021
30 Sep 2021	0%	+0%	$249,000	13,873	+13,873	NEW	$17.95	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.